Lv1
72 积分 2025-10-18 加入
Anti-PD-(L)1 plus chemotherapy in advanced PD-L1-negative nonsquamous non-small cell lung cancer: a systematic review and meta-analysis
21天前
已完结
卡瑞利珠单抗联合nab-PC方案治疗老年Ⅳ期驱动基因阴性肺鳞癌患者的疗效
29天前
已关闭
PD-(L)1 Inhibitor Monotherapy vs Chemoimmunotherapy for Advanced NSCLC With High PD-L1 Expression
1个月前
已完结
CYP2E1-dependent upregulation of SIRT7 is response to alcohol mediated metastasis in hepatocellular carcinoma
1个月前
已完结
Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial
1个月前
已完结
Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced Nonsquamous NSCLC: Extended Follow-Up of CameL Phase 3 Trial
1个月前
已完结
Outcomes With Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With NSCLC and Stable Brain Metastases: Pooled Analysis of KEYNOTE-021, -189, and -407
1个月前
已完结
Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC
1个月前
已完结
Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial
1个月前
已完结
Fibroblasts of disparate developmental origins harbor anatomically variant scarring potential
24天前
已驳回
Urinary metabolomics of complete Freund's adjuvant‐induced hyperalgesia in rats
24天前
已采纳
SGLT2 inhibitors activate pantothenate kinase in the human heart
24天前
已采纳
SGLT2 inhibitors activate pantothenate kinase in the human heart
24天前
已采纳
Improvement of the valuable compounds of fish waste through solid-state fermentation with probiotics
1个月前
已采纳
Redirected T-cell cytotoxicity identifies BRD9-PTGES axis as an immune-sensitising vulnerability in ovarian cancer
1个月前
已采纳
Spatial insights into psoriasis: A single-cell transcriptomics pipeline to study inflammatory skin disease
1个月前
已采纳
皖公网安备34019202002308
